CoChat

Impact of lithium alone and in combination with antidepressants on cytokine production in vitro

Open access
Petersein, Charlotte, Sack, Ulrich, Mergl, Roland, Schönherr, Jeremias, Schmidt, Frank M., Lichtblau, Nicole, Kirkby, Kenneth C., Bauer, Katrin, Himmerich, Hubertus · 2015 · Journal of Neural Transmission
Cited by 40

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Lithium is an important psychopharmacological agent for the treatment of unipolar as well as bipolar affective disorders. Lithium has a number of side effects such as hypothyroidism and aggravation of psoriasis. On the other hand, lithium has pro-inflammatory effects, which appear beneficial in some disorders associated with immunological deficits, such as human immunodeficiency virus (HIV) infection and systemic lupus erythematosus (SLE). Therefore, immunological characteristics of lithium may be an important consideration in individualized therapeutic decisions. We measured the levels of the cytokines interleukin (IL)-1ß, IL-2, IL-4, IL-6, IL-22, IL-17 and tumour necrosis factor (TNF)-α in the stimulated blood of thirty healthy subjects supplemented with lithium alone, the antidepressants citalopram, escitalopram or mirtazapine alone, the combination of each antidepressant with lithium, and a no drug control. These drugs were tested under three blood stimulant conditions: murine anti-human CD3 monoclonal antibody OKT3 and the 5C3 monoclonal antibody (OKT3/5C3), phytohemagglutinin (PHA), and unstimulated blood. Lithium, alone and in combination with any of the tested antidepressants, led to a consistent increase of IL-1ß, IL-6 and TNF-α levels in the unstimulated as well as the stimulated blood. In the OKT3/5C3- and PHA-stimulated blood, IL-17 production was significantly enhanced by lithium. Lithium additionally increased IL-2 concentrations significantly in PHA-stimulated blood. The data support the view that lithium has pro-inflammatory properties. These immunological characteristics may contribute to side effects of lithium, but may also explain its beneficial effects in patients suffering from HIV infection or SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00702-014-1328-6

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. Adair JR, Athwal DS, Bodmer MW, Bright SM, Collins AM, Pulito VL, Rao PE, Reedman R, Rothermel AL, Xu D, Zivin RA, Jolliffe LK (1994) Humanization of the murine anti-human CD3 monoclonal antibody OKT3. Hum Antibodies Hybridomas 5:41–47 · DOI · Paper page
  2. Arena A, Capozza AB, Orlando ME, Currò F, Losi E, Chillemi S, Mesiti M, Merendino RA (1997) In vitro effects of lithium chloride on TNF alpha and IL-6 production by monocytes from breast cancer patients. J Chemother 9:219–226. doi: 10.1179/joc.1997.9.3.219 · DOI
  3. Bauer M, Adli M, Bschor T, Pilhatsch M, Pfennig A, Sasse J, Schmid R, Lewitzka U (2010) Lithium’s emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology 62:36–42. doi: 10.1159/000314308 · DOI · Paper page
  4. Baumann P, Nil R, Souche A, Montaldi S, Baettig D, Lambert S, Uehlinger C, Kasas A, Amey M, Jonzier-Perey M (1996) A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 16:307–314 · DOI · Paper page
  5. Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G, Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (2004) The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37:243–265. doi: 10.1055/s-2004-832687 · DOI · Paper page
  6. Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W (1991) Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression. Cytokine 3:284–291. doi: 10.1016/1043-4666(91)90496-Z · DOI
  7. Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W (1992) Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 22:2181–2184. doi: 10.1002/eji.1830220835 · doi:10.1002/eji.1830220835
  8. Brandacher G, Margreiter R, Fuchs D (2007) Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation. Curr Drug Metab 8:273–282 · doi:10.2174/138920007780362536
  9. Bschor T, Bauer M (2013) Side effects and risk profile of lithium: critical assessment of a systematic review and meta-analysis. Nervenarzt 84:860–863. doi: 10.1007/s00115-013-3766-z · DOI
  10. Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 3:230–234. doi: 10.1055/s-2003-45135 · DOI · Paper page
  11. Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130:226–238. doi: 10.1016/j.pharmthera.2011.01.014 · DOI · Paper page
  12. Catena-Dell’Osso M, Rotella F, Dell’Osso A, Fagiolini A, Marazziti D (2013) Inflammation, serotonin and major depression. Curr Drug Targets 14:571–577 · DOI · Paper page
  13. Crews L, Patrick C, Achim CL, Everall IP, Masliah E (2009) Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci 10:1045–1063. doi: 10.3390/ijms10031045 · DOI
  14. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16–34 · doi:10.1128/cmr.13.1.16-34.2000 · Paper page
  15. Geoffroy PA, Bellivier F, Henry C (2014) Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines. Encephale S0013–7006(13):00250–00259. doi: 10.1016/j.encep.2013.10.007 · DOI
  16. Gomi T, Shiohara T, Munakata T, Imanishi K, Nagashima M (1991) Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis. Arch Dermatol 127:827–830 · doi:10.1001/archderm.1991.01680050071006
  17. Grandjean EM, Aubry JM (2009) Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety. CNS Drugs 23:397–418. doi: 10.2165/00023210-200923050-00004 · DOI · Paper page
  18. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367–6371 · DOI · Paper page
  19. Harvey BH, Meyer CL, Gallichio VS, Manji HK (2002) Lithium salts in AIDS and AIDS-related dementia. Psychopharmacol Bull 36:5–26
  20. Hemdan NY, Birkenmeier G, Wichmann G, Abu El-Saad AM, Krieger T, Conrad K, Sack U (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785–792. doi: 10.1016/j.autrev.2010.07.003 · DOI
  21. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollmächer T (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23:421–429. doi: 10.1016/j.eurpsy.2008.03.013 · DOI · Paper page
  22. Himmerich H, Berthold-Losleben M, Pollmächer T (2009) The relevance of the TNF-alpha system in psychiatric disorders. Fortschr Neurol Psychiatr 77:334–345. doi: 10.1055/s-0028-1109420 · DOI · Paper page
  23. Himmerich H, Fulda S, Sheldrick AJ, Plümäkers B, Rink L (2010a) IFN-gamma reduction by tricyclic antidepressants. Int J Psychiatry Med 40:413–424 · DOI · Paper page
  24. Himmerich H, Bartsch S, Hamer H, Mergl R, Schönherr J, Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U (2014) Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-CD40-stimulated blood in vitro. Oxid Med Cell Longev 2014:806162. doi: 10.1155/2014/806162 · DOI
  25. Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M, Pollmächer T (2000) Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23:13–19. doi: 10.1016/S0893-133X(00)00089-0 · DOI
  26. Ising M, Künzel HE, Binder EB, Nickel T, Modell S, Holsboer F (2005) The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 29:1085–1093. doi: 10.1016/j.pnpbp.2005.03.014 · DOI · Paper page
  27. Kibirige D, Luzinda K, Ssekitoleko R (2013) Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res 6:3. doi: 10.1186/1756-6614-6-3 · DOI
  28. Kirchner H, Kleinicke C, Digel W (1982) A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 48:213–219 · DOI · Paper page
  29. Kucharz EJ, Sierakowski SJ, Goodwin JS (1993) Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus. Immunopharmacol Immunotoxicol 15:515–523. doi: 10.3109/08923979309019728 · DOI
  30. Kum WW, Laupland KB, See RH, Chow AW (1993) Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J Clin Microbiol 31:2654–2660 · DOI
  31. Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I, HNRC Group (2006) Lithium improves HIV-associated neurocognitive impairment. AIDS 20:1885–1888. doi: 10.1097/01.aids.0000244208.49123.1b · DOI
  32. Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013) Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 25:592–603. doi: 10.3109/09540261.2013.813442 · DOI · Paper page
  33. Lotrich F (2012) Inflammatory cytokines, growth factors, and depression. Curr Pharm Des 18:5920–5935 · DOI · Paper page
  34. Maes M, Song C, Lin AH, Pioli R, Kenis G, Kubera M, Bosmans E (1999) In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology 143:401–407 · DOI
  35. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379:721–728. doi: 10.1016/S0140-6736(11)61516-X · DOI · Paper page
  36. Merendino RA, Mancuso G, Tomasello F, Gazzara D, Cusumano V, Chillemi S, Spadaro P, Mesiti M (1994) Effects of lithium carbonate on cytokine production in patients affected by breast cancer. J Biol Regul Homeost Agents 8:88–91
  37. Müller N (2014) Immunology of major depression. Neuroimmunomodulation 21:123–130. doi: 10.1159/000356540 · DOI · Paper page
  38. Müller-Oerlinghausen B, Berghöfer A, Bauer M (2002) Bipolar disorder. Lancet 359:241–247. doi: 10.1016/S0140-6736(02)07450-0 · DOI · Paper page
  39. Müller-Oerlinghausen B, Bauer M, Grof P (2012) Commentary on a recent review of lithium toxicity: what are its implications for clinical practice? BMC Med 10:132. doi: 10.1186/1741-7015-10-132 · DOI
  40. Murdaca G, Colombo BM, Puppo F (2011) The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 6:487–495. doi: 10.1007/s11739-011-0517-7 · DOI
  41. Paolieri F, Salmaso C, Battifora M, Montagna P, Pesce G, Bagnasco M, Richiusa P, Galluzzo A, Giordano C (1999) Possible pathogenetic relevance of interleukin-1 beta in “destructive” organ-specific autoimmune disease (Hashimoto’s thyroiditis). Ann N Y Acad Sci 876:221–228 · doi:10.1111/j.1749-6632.1999.tb07642.x
  42. Paquet P, Claessens N, Piérard-Franchimont C, Piérard GE (2005) Cutaneous adverse effects of lithium. Rev Med Liege 60:885–887
  43. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141. doi: 10.1038/ni1261 · DOI · Paper page
  44. Pound JD, Challa A, Holder MJ, Armitage RJ, Dower SK, Fanslow WC, Kikutani H, Paulie S, Gregory CD, Gordon J (1999) Minimal crosslinking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int Immunol 11:11–20. doi: 10.1093/intimm/11.1.11 · DOI
  45. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522 · DOI · Paper page
  46. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996) Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78:83–85 · DOI
  47. Simons PJ, Delemarre FG, Drexhage HA (1998) Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role of interleukin-1beta and interleukin-6. Endocrinology 139:3148–3156. doi: 10.1210/endo.139.7.6110 · DOI
  48. Sztein MB, Simon GL, Parenti DM, Scheib R, Goldstein AL, Goodman R, DiGioia R, Paxton H, Skotnicki AB, Schulof RS (1987) In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex. Clin Immunol Immunopathol 44:51–62. doi: 10.1016/0090-1229(87)90051-1 · doi:10.1016/0090-1229(87)90051-1
  49. Tang H, Tan G, Guo Q, Pang R, Zeng F (2009) Abnormal activation of the Akt-GSK3beta signaling pathway in peripheral blood T cells from patients with systemic lupus erythematosus. Cell Cycle 8:2789–2793. doi: 10.1159/000350097 · DOI
  50. Tarhan F, Orük G, Niflioğlu O, Ozer S (2013) Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF α treatment. Rheumatol Int 33:853–857. doi: 10.1007/s00296-012-2438-9 · DOI
  51. Wells JE, Cross NB, Richardson AK (2012) Toxicity profile of lithium. Lancet 379:2338. doi: 10.1016/S0140-6736(12)61012-5 · DOI
  52. Wilson R, Fraser WD, McKillop JH, Smith J, O’Reilly DS, Thomson JA (1989) The “in vitro” effects of lithium on the immune system. Autoimmunity 4:109–114 · DOI

Cited by

See all 40

Metadata

Authors
Petersein, C., Sack, U., Mergl, R., Schönherr, J., Schmidt, F. M., Lichtblau, N., Kirkby, K. C., Bauer, K., & Himmerich, H.
Venue
Journal of Neural Transmission
Published
2014-11-07
Volume
122
Issue
1
Pages
109-122
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W2080923533
Cited by
40
References
17
FWCI
3.82
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.